Regorafenib-induced renal-limited thrombotic microangiopathy: a case report and review of literatures

BACKGROUND: Regorafenib belongs to a sub-group of small-molecule multi-targeted tyrosine kinase inhibitors(TKIs). In various studies with respect to the side-effect of regorafenib, drug-associated proteinuria standardly qualified to be defined as nephrotic syndrome was rarely reported as well as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Qinghua, Guo, Na, Zhou, Xueli, Xu, Huan, Lei, Song, Fu, Ping, Zhong, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933930/
https://www.ncbi.nlm.nih.gov/pubmed/35305559
http://dx.doi.org/10.1186/s12882-021-02656-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933930/
https://www.ncbi.nlm.nih.gov/pubmed/35305559
http://dx.doi.org/10.1186/s12882-021-02656-9

Ejemplares similares